Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fluid Therapy | 4 | 2019 | 628 | 1.54 | Why? |
| Sepsis | 14 | 2019 | 3517 | 1.13 | Why? |
| Shock, Septic | 8 | 2018 | 1313 | 1.04 | Why? |
| Resuscitation | 6 | 2019 | 638 | 0.89 | Why? |
| Glycocalyx | 1 | 2019 | 110 | 0.70 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2018 | 265 | 0.63 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.59 | Why? |
| Emergency Service, Hospital | 18 | 2021 | 14232 | 0.54 | Why? |
| Microcirculation | 4 | 2018 | 447 | 0.51 | Why? |
| Lactic Acid | 4 | 2018 | 393 | 0.44 | Why? |
| Endothelial Cells | 2 | 2019 | 2048 | 0.43 | Why? |
| Lactates | 1 | 2010 | 59 | 0.43 | Why? |
| Critical Illness | 7 | 2019 | 17281 | 0.42 | Why? |
| Fever | 2 | 2018 | 7795 | 0.42 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.35 | Why? |
| Hospital Mortality | 14 | 2019 | 22087 | 0.31 | Why? |
| Blood Coagulation Tests | 1 | 2010 | 855 | 0.28 | Why? |
| Point-of-Care Testing | 1 | 2018 | 2782 | 0.28 | Why? |
| Syncope | 2 | 2019 | 238 | 0.28 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.27 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.27 | Why? |
| Accidental Falls | 2 | 2019 | 448 | 0.26 | Why? |
| Organ Dysfunction Scores | 6 | 2019 | 1475 | 0.25 | Why? |
| Prospective Studies | 21 | 2021 | 43301 | 0.24 | Why? |
| Diabetes Mellitus | 2 | 2017 | 8207 | 0.23 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.23 | Why? |
| Shock | 2 | 2018 | 1868 | 0.21 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.21 | Why? |
| C-Reactive Protein | 3 | 2019 | 7972 | 0.20 | Why? |
| Fractures, Closed | 1 | 2019 | 13 | 0.20 | Why? |
| Hospitalization | 10 | 2021 | 54280 | 0.20 | Why? |
| Multiple Organ Failure | 1 | 2010 | 1724 | 0.20 | Why? |
| United States | 19 | 2021 | 46150 | 0.19 | Why? |
| Rib Fractures | 1 | 2019 | 26 | 0.19 | Why? |
| Regional Blood Flow | 2 | 2017 | 172 | 0.19 | Why? |
| Intravital Microscopy | 1 | 2018 | 34 | 0.19 | Why? |
| Pancreatitis | 2 | 2018 | 688 | 0.19 | Why? |
| Syndecan-1 | 1 | 2019 | 65 | 0.19 | Why? |
| Judgment | 1 | 2019 | 98 | 0.19 | Why? |
| Receptor, TIE-2 | 1 | 2018 | 42 | 0.18 | Why? |
| Medical Staff, Hospital | 2 | 2019 | 1258 | 0.18 | Why? |
| Myxovirus Resistance Proteins | 1 | 2018 | 77 | 0.18 | Why? |
| Intracranial Hemorrhage, Traumatic | 1 | 2017 | 6 | 0.18 | Why? |
| Adrenergic beta-Agonists | 1 | 2018 | 93 | 0.18 | Why? |
| Immunocompetence | 1 | 2019 | 280 | 0.17 | Why? |
| Work | 1 | 2020 | 342 | 0.17 | Why? |
| Immunomagnetic Separation | 1 | 2017 | 55 | 0.17 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.17 | Why? |
| Middle Aged | 39 | 2021 | 270681 | 0.17 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.17 | Why? |
| Hospital Rapid Response Team | 1 | 2018 | 100 | 0.16 | Why? |
| Single-Blind Method | 2 | 2020 | 1283 | 0.16 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Endotoxemia | 1 | 2018 | 143 | 0.16 | Why? |
| Antigens, Surface | 1 | 2017 | 181 | 0.16 | Why? |
| Prognosis | 7 | 2018 | 32490 | 0.16 | Why? |
| Watchful Waiting | 1 | 2018 | 276 | 0.16 | Why? |
| Oximetry | 1 | 2021 | 658 | 0.16 | Why? |
| Male | 43 | 2021 | 367725 | 0.15 | Why? |
| Female | 43 | 2021 | 380317 | 0.15 | Why? |
| Critical Care | 2 | 2018 | 14081 | 0.15 | Why? |
| Lipase | 1 | 2017 | 153 | 0.15 | Why? |
| Blood Preservation | 1 | 2016 | 191 | 0.15 | Why? |
| Malpractice | 1 | 2018 | 165 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.14 | Why? |
| Craniocerebral Trauma | 1 | 2017 | 160 | 0.14 | Why? |
| Telecommunications | 1 | 2020 | 551 | 0.14 | Why? |
| Automation | 1 | 2017 | 429 | 0.14 | Why? |
| APACHE | 1 | 2017 | 682 | 0.14 | Why? |
| Biomarkers | 10 | 2019 | 23361 | 0.14 | Why? |
| Aged, 80 and over | 12 | 2019 | 88759 | 0.14 | Why? |
| Intensive Care Units | 6 | 2019 | 29594 | 0.14 | Why? |
| Hypotension | 1 | 2018 | 392 | 0.14 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.14 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Humans | 54 | 2021 | 930598 | 0.13 | Why? |
| Aged | 26 | 2021 | 215776 | 0.13 | Why? |
| Angiopoietin-2 | 3 | 2019 | 125 | 0.13 | Why? |
| Ambulatory Care Facilities | 3 | 2020 | 2063 | 0.13 | Why? |
| Erythrocyte Transfusion | 1 | 2016 | 386 | 0.12 | Why? |
| Predictive Value of Tests | 5 | 2017 | 9537 | 0.11 | Why? |
| Academic Medical Centers | 3 | 2020 | 3088 | 0.11 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Socioeconomic Factors | 3 | 2020 | 8495 | 0.11 | Why? |
| Critical Pathways | 2 | 2019 | 1587 | 0.11 | Why? |
| Erythrocytes | 1 | 2016 | 617 | 0.11 | Why? |
| Outpatients | 2 | 2021 | 3417 | 0.10 | Why? |
| Hospitals, Urban | 2 | 2019 | 950 | 0.10 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.10 | Why? |
| Triage | 3 | 2018 | 7151 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Adult | 23 | 2021 | 244371 | 0.10 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2018 | 994 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| Appendicitis | 1 | 2018 | 946 | 0.09 | Why? |
| Interleukin-6 | 4 | 2019 | 7522 | 0.09 | Why? |
| Diagnostic Tests, Routine | 2 | 2018 | 2643 | 0.09 | Why? |
| Emergency Medicine | 1 | 2018 | 936 | 0.09 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.09 | Why? |
| Mouth Floor | 2 | 2018 | 33 | 0.09 | Why? |
| Guidelines as Topic | 1 | 2021 | 2844 | 0.09 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Logistic Models | 4 | 2021 | 9089 | 0.09 | Why? |
| Chi-Square Distribution | 1 | 2010 | 961 | 0.08 | Why? |
| Boston | 2 | 2021 | 929 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Comorbidity | 4 | 2019 | 34796 | 0.08 | Why? |
| Length of Stay | 3 | 2019 | 11042 | 0.07 | Why? |
| Heparin | 1 | 2019 | 2600 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Consensus | 2 | 2018 | 6345 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.06 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.06 | Why? |
| Radiography, Thoracic | 2 | 2019 | 5486 | 0.06 | Why? |
| Cardiac Surgical Procedures | 1 | 2016 | 1931 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2018 | 6653 | 0.06 | Why? |
| Population Surveillance | 2 | 2017 | 4967 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Oxygen | 1 | 2016 | 3715 | 0.06 | Why? |
| Sensitivity and Specificity | 3 | 2018 | 22971 | 0.06 | Why? |
| Cohort Studies | 7 | 2019 | 36005 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Cytokines | 2 | 2017 | 15010 | 0.06 | Why? |
| Retrospective Studies | 10 | 2019 | 105322 | 0.05 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| Machine Learning | 1 | 2017 | 4395 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Angiopoietin-1 | 1 | 2019 | 25 | 0.05 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Hyperglycemia | 1 | 2011 | 1363 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Multivariate Analysis | 1 | 2010 | 5440 | 0.05 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.05 | Why? |
| Microscopy, Video | 1 | 2018 | 63 | 0.05 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.05 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.05 | Why? |
| Adaptive Immunity | 1 | 2011 | 2585 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 229 | 0.05 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.05 | Why? |
| Sampling Studies | 1 | 2019 | 386 | 0.05 | Why? |
| Odds Ratio | 1 | 2010 | 5861 | 0.04 | Why? |
| Cell Adhesion | 1 | 2018 | 230 | 0.04 | Why? |
| Tumor Necrosis Factors | 1 | 2017 | 28 | 0.04 | Why? |
| Isoprostanes | 1 | 2017 | 22 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Hospitals, University | 1 | 2010 | 4173 | 0.04 | Why? |
| Intubation | 1 | 2019 | 437 | 0.04 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
| Antithrombin III | 1 | 2017 | 67 | 0.04 | Why? |
| Sheep | 1 | 2018 | 420 | 0.04 | Why? |
| Blood Cells | 1 | 2017 | 104 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Thrombomodulin | 1 | 2017 | 121 | 0.04 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.04 | Why? |
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2017 | 120 | 0.04 | Why? |
| Permeability | 1 | 2017 | 238 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2016 | 137 | 0.04 | Why? |
| Vital Signs | 1 | 2017 | 257 | 0.04 | Why? |
| Thrombosis | 1 | 2018 | 7504 | 0.04 | Why? |
| B7-H1 Antigen | 1 | 2019 | 541 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2019 | 714 | 0.04 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| International Classification of Diseases | 1 | 2017 | 265 | 0.03 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Washington | 1 | 2019 | 1722 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Clinical Deterioration | 1 | 2018 | 473 | 0.03 | Why? |
| Interleukin-8 | 1 | 2019 | 964 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Immunity, Innate | 1 | 2011 | 6570 | 0.03 | Why? |
| Health Facilities | 1 | 2021 | 1230 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Aftercare | 1 | 2021 | 1637 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| von Willebrand Factor | 1 | 2017 | 668 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2019 | 1609 | 0.03 | Why? |
| Tissue Plasminogen Activator | 1 | 2017 | 778 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Hemostasis | 1 | 2017 | 811 | 0.03 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.03 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2018 | 1062 | 0.02 | Why? |
| Decision Support Techniques | 1 | 2016 | 903 | 0.02 | Why? |
| Peptide Hydrolases | 1 | 2017 | 1269 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.02 | Why? |
| Trauma Centers | 1 | 2017 | 1195 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Tomography, X-Ray Computed | 3 | 2019 | 25144 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Smartphone | 1 | 2017 | 1840 | 0.02 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Clinical Competence | 1 | 2019 | 3263 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Mobile Applications | 1 | 2017 | 3032 | 0.01 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2017 | 5993 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2016 | 17020 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.01 | Why? |
Shapiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(244)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(398)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_